Advertisement

Breast Cancer Research and Treatment

, Volume 146, Issue 2, pp 235–244 | Cite as

Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis

  • Francisco E. Vera-Badillo
  • Marc Napoleone
  • Alberto Ocana
  • Arnoud J. Templeton
  • Bostjan Seruga
  • Mustafa Al-Mubarak
  • Hashem AlHashem
  • Ian F. Tannock
  • Eitan AmirEmail author
Review

Abstract

Women with multifocal or multicentric breast tumors (multifocality henceforth) have been reported to have greater probability of nodal metastasis and relapse and worse survival than women with unifocal tumors. However, these associations have been inconsistent and multifocality is not taken into account by staging guidelines and prognostic models. A systematic review of electronic databases identified publications exploring the association between multifocality and overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), and loco-regional relapse (LRR). The hazard ratios (HRs) for OS and DFS for multifocal compared to unifocal tumors were extracted from multivariable analyses and included in a meta-analysis. For studies not reporting multivariable analyses, odds ratios (OR) were estimated from Kaplan–Meier curves for all endpoints at 5 and 10 years. Twenty-two studies comprising 67,557 women were included. Multifocality was reported in 9.5 % of patients. Classical prognostic factors were well balanced between unifocal and multifocal populations. In multivariable analyses, multifocality was associated with significantly worse OS (HR 1.65; P = 0.02), and a non-significant association with worse DFS (HR 1.96; P = 0.07). In univariable analyses, multifocality was associated with worse OS, DFS, DSS, and LRR at 5 years (OR 1.39, P = 0.02; OR 1.52, P = 0.02; OR 1.56, P = 0.03; and OR 3.23, P = 0.02, respectively). Similar estimates were observed at 10 years, but statistical significance was only reached for DSS and LRR. Mutifocality appears to be associated with a worse prognosis, however, substantial inter-study heterogeneity limits the precise determination of increased risk. Further validation of the independent prognostic impact of multifocality is warranted.

Keywords

Breast cancer Multifocality/multicentricity Prognosis 

Notes

Acknowledgments

The authors would like to thank Junhui Zhang, information specialist at the Princess Margaret Cancer Centre Library, for her help with the database search.

Funding

This study was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico (Ref: 214638) to FEV-B.

Conflict of interest

All authors disclose that they have no relevant conflicts of interest.

References

  1. 1.
    National Comprehensive Cancer Network (2013) Breast cancer (version 3). Accessed 11 Nov 2013. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
  2. 2.
    Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826PubMedCrossRefGoogle Scholar
  3. 3.
    Van ‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–536PubMedCrossRefGoogle Scholar
  4. 4.
    National Cancer Institute, NCI (2000) Genetic testing or clinical assessment in determining the need for chemotherapy in women with breast cancer that involves no more than 3 lymph nodes. In: ClinicalTrials.gov (internet). National Library of Medicine (US), Bethesda. Accessed 21 May 2014. http://clinicaltrials.gov/ct2/show/NCT00433589. NLM Identifier: NCT00433589
  5. 5.
    Ustaalioglu BO, Bilici A, Kefeli U, Seker M, Oncel M, Gezen C, Gumus M, Demirelli F (2012) The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience. Am J Clin Oncol 35(6):580–586PubMedCrossRefGoogle Scholar
  6. 6.
    Fowble B, Yeh IT, Schultz DJ, Solin LJ, Rosato EF, Jardines L, Hoffman J, Eisenberg B, Weiss MC, Hanks G (1993) The role of mastectomy in patients with stage I–II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys 27(3):567–573PubMedCrossRefGoogle Scholar
  7. 7.
    Eeles R, Knee G, Jhavar S, Mangion J, Ebbs S, Gui G, Thomas S, Coppen M, A’Hern R, Gray S et al (2011) Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat 129(3):703–716PubMedCrossRefGoogle Scholar
  8. 8.
    Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA (2009) Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 117(2):365–370PubMedCrossRefGoogle Scholar
  9. 9.
    Fisher B, Slack NH, Bross ID (1969) Cancer of the breast: size of neoplasm and prognosis. Cancer 24(5):1071–1080PubMedCrossRefGoogle Scholar
  10. 10.
    Edge SB, Byrd DR, Fritzz AG et al (2010) AJCC cancer staging manual, 7th edn. Springer, New YorkGoogle Scholar
  11. 11.
    Coombs NJ, Boyages J (2005) Multifocal and multicentric breast cancer: does each focus matter? [Erratum appears in J Clin Oncol. 2006 Apr 1;24(10):1648]. J Clin Oncol 23(30):7497–7502PubMedCrossRefGoogle Scholar
  12. 12.
    Boyages J, Jayasinghe UW, Coombs N (2010) Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur J Cancer 46(11):1990–1996PubMedCrossRefGoogle Scholar
  13. 13.
    Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T (2009) Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg 208(1):67–74PubMedCrossRefGoogle Scholar
  14. 14.
    Joergensen LE, Gunnarsdottir KA, Lanng C, Moeller S, Rasmussen BB (2008) Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001. Breast 17(6):587–591PubMedCrossRefGoogle Scholar
  15. 15.
    Pedersen L, Gunnarsdottir KA, Rasmussen BB, Moeller S, Lanng C (2004) The prognostic influence of multifocality in breast cancer patients. Breast 13(3):188–193PubMedCrossRefGoogle Scholar
  16. 16.
    Chung AP, Huynh K, Kidner T, Mirzadehgan P, Sim M-S, Giuliano AE (2012) Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. J Am Coll Surg 215(1):137–146 discussion 146–147PubMedCrossRefGoogle Scholar
  17. 17.
    Bendifallah S, Werkoff G, Borie-Moutafoff C, Antoine M, Chopier J, Gligorov J, Uzan S, Coutant C, Rouzier R (2010) Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol 19(4):e115–e123PubMedCrossRefGoogle Scholar
  18. 18.
    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP (2005) Meta-analysis when only the median survival times are known: a comparison with individual patient data results. Int J Technol Assess Health Care 21(1):119–125PubMedCrossRefGoogle Scholar
  20. 20.
    Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323(7305):157–162PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Oh JL, Dryden MJ, Woodward WA, Yu T-K, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH et al (2006) Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24(31):4971–4975PubMedCrossRefGoogle Scholar
  22. 22.
    Okumura S, Mitsumori M, Yamauchi C, Kawamura S, Oya N, Nagata Y, Hiraoka M, Kokubo M, Mise K, Kodama H (2004) Feasibility of breast-conserving therapy for macroscopically multiple ipsilateral breast cancer. Int J Radiat Oncol Biol Phys 59(1):146–151PubMedCrossRefGoogle Scholar
  23. 23.
    Litton JK, Eralp Y, Gonzalez-Angulo AM, Broglio K, Uyei A, Hortobagyi GN, Arun B (2007) Multifocal breast cancer in women ≤35 years old. Cancer 110(7):1445–1450PubMedCrossRefGoogle Scholar
  24. 24.
    Lynch SP, Lei X, Chavez-MacGregor M, Hsu L, Meric-Bernstam F, Buchholz TA, Zhang A, Hortobagyi GN, Valero V, Gonzalez-Angulo AM (2012) Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 23(12):3063–3069PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Tiong LU, Parkyn R, Walters D, Field J, Lai C, Walsh DCA (2011) Dilemma in multifocal breast cancer—largest versus aggregate diameter. ANZ J Surg 81(9):614–618PubMedCrossRefGoogle Scholar
  26. 26.
    Wilson LD, Beinfield M, McKhann CF, Haffty BG (1993) Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers. Cancer 72(1):137–142PubMedCrossRefGoogle Scholar
  27. 27.
    Egan RL (1982) Multicentric breast carcinomas: clinical–radiographic–pathologic whole organ studies and 10-year survival. Cancer 49(6):1123–1130PubMedCrossRefGoogle Scholar
  28. 28.
    Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA (2002) Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer 94(7):1910–1916PubMedCrossRefGoogle Scholar
  29. 29.
    Vlastos G, Rubio IT, Mirza NQ, Newman LA, Aurora R, Alderfer J, Buzdar AU, Singletary SE (2000) Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 7(8):581–587PubMedCrossRefGoogle Scholar
  30. 30.
    Weissenbacher TM, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D, Rack B, Schindlbeck C, Friese K, Dian D (2010) Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 122(1):27–34PubMedCrossRefGoogle Scholar
  31. 31.
    Pekar G, Hofmeyer S, Tabar L, Tarjan M, Chen TH-H, Yen AM-F, Chiu SY-H, Hellberg D, Gere M, Tot T (2013) Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes. Cancer 119(6):1132–1139PubMedCrossRefGoogle Scholar
  32. 32.
    Tot T, Gere M, Pekar G, Tarjan M, Hofmeyer S, Hellberg D, Lindquist D, Chen TH-H, Yen AM-F, Chiu SY-H et al (2011) Breast cancer multifocality, disease extent, and survival. Hum Pathol 42(11):1761–1769PubMedCrossRefGoogle Scholar
  33. 33.
    Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD (2001) The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50(3):735–742PubMedCrossRefGoogle Scholar
  34. 34.
    Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier JM (1990) Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 212(1):38–44PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Black WC, Haggstrom DA, Welch HG (2002) All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 94(3):167–173PubMedCrossRefGoogle Scholar
  36. 36.
    Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106PubMedCrossRefGoogle Scholar
  37. 37.
    Nakamura R, Song JP, Isogaki J, Kitayama Y, Sugimura H (2003) Multiple (multicentric and multifocal) cancers in the ipsilateral breast with different histologies: profiles of chromosomal numerical abnormality. Jpn J Clin Oncol 33(9):463–469PubMedCrossRefGoogle Scholar
  38. 38.
    Buggi F, Folli S, Curcio A, Casadei-Giunchi D, Rocca A, Pietri E, Medri L, Serra L (2012) Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol 23(8):2042–2046PubMedCrossRefGoogle Scholar
  39. 39.
    Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, Hayes DF, Kleer C, O’Malley FP, Page DL et al (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133(10):1515–1538PubMedGoogle Scholar
  40. 40.
    Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA (2012) Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol 23(4):876–881PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Francisco E. Vera-Badillo
    • 1
    • 4
  • Marc Napoleone
    • 1
    • 4
  • Alberto Ocana
    • 2
  • Arnoud J. Templeton
    • 1
    • 4
  • Bostjan Seruga
    • 3
  • Mustafa Al-Mubarak
    • 1
    • 4
  • Hashem AlHashem
    • 1
    • 4
  • Ian F. Tannock
    • 1
    • 4
  • Eitan Amir
    • 1
    • 4
    Email author
  1. 1.Division of Medical Oncology & HematologyPrincess Margaret Cancer CentreTorontoCanada
  2. 2.Translational Research UnitAlbacete University HospitalAlbaceteSpain
  3. 3.Sector of Medical OncologyInstitute of Oncology LjubljanaLjubljanaSlovenia
  4. 4.Department of MedicineUniversity of TorontoTorontoCanada

Personalised recommendations